London
· Delayed Price · Currency is GBP · Price in NOK Hofseth BioCare ASA Statistics
Total Valuation
LON:0Q6H has a market cap or net worth of GBP 57.85 million. The enterprise value is 68.28 million.
| Market Cap | 57.85M |
| Enterprise Value | 68.28M |
Important Dates
The next estimated earnings date is Friday, May 16, 2025.
| Earnings Date | May 16, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +4.26% |
| Shares Change (QoQ) | -0.04% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 267.74M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.10 |
| PB Ratio | 13.42 |
| P/TBV Ratio | 14.30 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -7.87 |
| EV / Sales | 3.56 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -79.20 |
Financial Position
The company has a current ratio of 0.67, with a Debt / Equity ratio of 2.79.
| Current Ratio | 0.67 |
| Quick Ratio | 0.26 |
| Debt / Equity | 2.79 |
| Debt / EBITDA | n/a |
| Debt / FCF | -13.94 |
| Interest Coverage | -6.70 |
Financial Efficiency
Return on equity (ROE) is -240.93% and return on invested capital (ROIC) is -23.70%.
| Return on Equity (ROE) | -240.93% |
| Return on Assets (ROA) | -17.96% |
| Return on Invested Capital (ROIC) | -23.70% |
| Return on Capital Employed (ROCE) | -60.76% |
| Revenue Per Employee | 266,711 |
| Profits Per Employee | -123,950 |
| Employee Count | 71 |
| Asset Turnover | 0.73 |
| Inventory Turnover | 2.45 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -9.55% in the last 52 weeks. The beta is 0.57, so LON:0Q6H's price volatility has been lower than the market average.
| Beta (5Y) | 0.57 |
| 52-Week Price Change | -9.55% |
| 50-Day Moving Average | 3.92 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 34.46 |
| Average Volume (20 Days) | 72,495 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, LON:0Q6H had revenue of GBP 18.67 million and -8.68 million in losses. Loss per share was -0.02.
| Revenue | 18.67M |
| Gross Profit | 6.75M |
| Operating Income | -7.39M |
| Pretax Income | -8.68M |
| Net Income | -8.68M |
| EBITDA | -4.59M |
| EBIT | -7.39M |
| Loss Per Share | -0.02 |
Balance Sheet
The company has 1.80 million in cash and 12.01 million in debt, giving a net cash position of -10.22 million.
| Cash & Cash Equivalents | 1.80M |
| Total Debt | 12.01M |
| Net Cash | -10.22M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 4.31M |
| Book Value Per Share | 0.01 |
| Working Capital | -3.96M |
Cash Flow
In the last 12 months, operating cash flow was -690,293 and capital expenditures -171,835, giving a free cash flow of -862,128.
| Operating Cash Flow | -690,293 |
| Capital Expenditures | -171,835 |
| Free Cash Flow | -862,128 |
| FCF Per Share | n/a |
Margins
Gross margin is 36.15%, with operating and profit margins of -39.57% and -46.47%.
| Gross Margin | 36.15% |
| Operating Margin | -39.57% |
| Pretax Margin | -46.47% |
| Profit Margin | -46.47% |
| EBITDA Margin | -24.59% |
| EBIT Margin | -39.57% |
| FCF Margin | n/a |
Dividends & Yields
LON:0Q6H does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.26% |
| Shareholder Yield | -4.26% |
| Earnings Yield | -15.00% |
| FCF Yield | -1.49% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |